Creative Planning’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,784
Closed -$1.2M 2188
2020
Q1
$1.2M Sell
6,784
-729
-10% -$137K ﹤0.01% 576
2019
Q4
$1.44M Sell
7,513
-1,562
-17% -$282K ﹤0.01% 641
2019
Q3
$1.53M Sell
9,075
-2,669
-23% -$435K 0.01% 584
2019
Q2
$1.97M Buy
11,744
+1,746
+17% +$242K 0.01% 503
2019
Q1
$1.46M Sell
9,998
-1,765
-15% -$256K 0.01% 580
2018
Q4
$1.57M Sell
11,763
-2,689
-19% -$441K 0.01% 488
2018
Q3
$2.75M Sell
14,452
-2,991
-17% -$549K 0.01% 398
2018
Q2
$2.91M Sell
17,443
-851
-5% -$137K 0.01% 382
2018
Q1
$3.08M Sell
18,294
-507
-3% -$85K 0.01% 357
2017
Q4
$3.08M Sell
18,801
-1,460
-7% -$262K 0.01% 348
2017
Q3
$4.15M Buy
20,261
+4,250
+27% +$988K 0.02% 273
2017
Q2
$3.89M Sell
16,011
-2,295
-13% -$539K 0.02% 271
2017
Q1
$4.37M Sell
18,306
-4,460
-20% -$1.04M 0.02% 230
2016
Q4
$4.78M Buy
22,766
+1,556
+7% +$322K 0.03% 211
2016
Q3
$4.88M Buy
21,210
+2,799
+15% +$684K 0.03% 208
2016
Q2
$4.25M Buy
18,411
+5,283
+40% +$1.22M 0.03% 190
2016
Q1
$3.52M Sell
13,128
-7,360
-36% -$2.11M 0.03% 200
2015
Q4
$6.4M Buy
20,488
+572
+3% +$170K 0.05% 137
2015
Q3
$5.41M Buy
19,916
+513
+3% +$158K 0.05% 156
2015
Q2
$5.89M Sell
19,403
-5,455
-22% -$1.63M 0.05% 135
2015
Q1
$7.4M Buy
24,858
+9,799
+65% +$2.79M 0.07% 117
2014
Q4
$3.88M Buy
15,059
+1,400
+10% +$350K 0.04% 166
2014
Q3
$3.3M Buy
13,659
+1,743
+15% +$390K 0.04% 172
2014
Q2
$2.66M Sell
11,916
-939
-7% -$194K 0.03% 188
2014
Q1
$2.65M Buy
12,855
+4,931
+62% +$977K 0.04% 161
2013
Q4
$1.33M Buy
+7,924
New +$1.24M 0.02% 251
2013
Q3
Sell
-3,370
Closed -$425K 3409
2013
Q2
$425K Buy
+3,370
New +$382K 0.01% 446

Other funds holding AGN

Creative Planning's AGN Position: Q2 2020 in Review

Creative Planning sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,784 shares — an estimated $1.2M sold.

Creative Planning first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $7.4M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Creative Planning reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Creative Planning sold 6,784 Allergan plc shares in Q2 2020, an estimated $1.2M.
  • Creative Planning first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Creative Planning's Allergan plc position peaked at $7.4M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.